Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Explore enhancements to budgeting strategies and adopt practical tweaks to optimize spending and savings.
20,040 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
Investors are flocking to renewable energy stocks as policy support and expanding clean-energy projects push the sect...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
Beyond Meat faces a double headwind: a tepid forecast and a crowded protein-drink market. Investors are reeling as re...
Peloton posted a GAAP profit in its latest quarter and raised full-year guidance, sparking an 11% premarket jump as i...
In 2026 market conditions, the Vanguard High Dividend Yield ETF posted stronger five-year gains than SCHD, while deca...
Arthur Hayes, BitMEX co-founder and Maelstrom CIO, projects Bitcoin hitting $125K by year-end as liquidity returns. T...
Florida citrus growers face a multi-year test as disease, drought, and storms erode yields and profits. Farmers are a...
A hedge fund with a high-conviction AI thesis is pushing a mid-cap stock higher, shedding light on how big bets in ar...
Trump heads Beijing high-stakes summit as markets watch for any change in US-China policy on crypto, potentially resh...
Mortgage rates move higher for a second straight week, delaying any spring surge in activity. Analysts say inflation ...